State and municipal authorities have begun a period of valuation of public transport in Puerto Vallarta, with which they will determine the possibility of reducing 50 percent of public transport units in the city center, according to Luis Alberto Romero Chávez, president of the company Costa Pacífico (UNIBUS).
Chávez said that he is in talks with both the municipal government and the state government to see if they could create transfer centers, which would be located on Francisco Medina Ascencio Avenue at the height of the Agustín Flores Contreras Sports Center in both directions.
He explained, “If the user goes in a truck that does not reach the center, they could transfer to another bus to access their destination downtown, for now only the study is being conducted and no official plans have been determined.”
He did note that transfers would be free to users entering and exiting the city center.
“The only thing we are looking for is to give a boost to the downtown area of Puerto Vallarta, as the municipal president and the governor mentioned, that the downtown area has more life again and one of the proposals that are being made is to address congestion in the city center, taking out 50 percent of the public transport units so that restaurants, hotels, and shops that are in that area have a better flow of vehicles ”.
Romero Chavez said that this does not seek to cause an upset with bus users, but that anyone who goes to the city center can enjoy the area with a lower flow of buses and congestion on the already crowded narrow streets of Puerto Vallarta.
And finally, he pointed out, there are days when 450 trucks enter the city center, but from the start of the boardwalk, many of the units only have three or four passengers and the only thing they cause is traffic and an inconvenience to pedestrians.
Scientists have recently developed advanced protocols harnessing the power of exosomes to create a new class of therapeutics to improve the effectiveness of stem cell therapy. In particular, they have developed new protocols for neurological diseases such as Alzheimer´s, Parkinson´s, Autism and Multiple Sclerosis. Read More